Clinical Neurosciences
1 of 3
9 of 111
- Alemtuzumab is a budget-saving alternative to fingolimod and natalizumab in the treatment of highly active relapsing-remitting multiple sclerosis (2020)
- A letter to the editor concerning "Geochemistry of multiple sclerosis in Finland" (2023)
- Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome (2013)
- Alterations in microstructure and local fiber orientation of the white matter are associated with outcome following mild traumatic brain injury (2020)
- Altered orbitofrontal sulcogyral patterns in gambling disorder: a multicenter study (2019)
- A metabolic profile of xenon and metabolite associations with 6-month mortality after out-of-hospital cardiac arrest : A post-hoc study of the randomised Xe-Hypotheca trial (2024)
- Amyotrophic Lateral Sclerosis in Southwestern and Eastern Finland (2023)
- Analysis of the Delay Components in the Treatment of Status Epilepticus (2013)
- Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage (2024)
- Aneurysmaattinen subaraknoidaalivuoto (aSAV) (2024)
UTU Research Portal